296 related articles for article (PubMed ID: 7980850)
1. Lack of relationship between the Epstein-Barr virus and the antiperinuclear factor/'perinuclear antigen' system in rheumatoid arthritis.
Buisson M; Berthelot JM; Le Goff P; Chastel C; Lamour A; Seigneurin JM; Youinou P
J Autoimmun; 1994 Aug; 7(4):485-95. PubMed ID: 7980850
[TBL] [Abstract][Full Text] [Related]
2. Antiperinuclear factor, a rheumatoid arthritis specific autoantibody: its relation to Epstein-Barr virus.
Westgeest AA; van Loon AM; van der Logt JT; van de Putte LB; Boerbooms AM
J Rheumatol; 1989 May; 16(5):626-30. PubMed ID: 2547060
[TBL] [Abstract][Full Text] [Related]
3. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases.
Marchini B; Dolcher MP; Sabbatini A; Klein G; Migliorini P
J Autoimmun; 1994 Apr; 7(2):179-91. PubMed ID: 7518683
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis.
Blaschke S; Schwarz G; Moneke D; Binder L; Müller G; Reuss-Borst M
J Rheumatol; 2000 Apr; 27(4):866-73. PubMed ID: 10782808
[TBL] [Abstract][Full Text] [Related]
5. The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies.
Sebbag M; Simon M; Vincent C; Masson-Bessière C; Girbal E; Durieux JJ; Serre G
J Clin Invest; 1995 Jun; 95(6):2672-9. PubMed ID: 7539459
[TBL] [Abstract][Full Text] [Related]
6. Antibody to the rheumatoid arthritis nuclear antigen. Its relationship to in vivo Epstein-Barr virus infection.
Catalano MA; Carson DA; Niederman JC; Feorino P; Vaughan JH
J Clin Invest; 1980 May; 65(5):1238-42. PubMed ID: 6245108
[TBL] [Abstract][Full Text] [Related]
7. The perinuclear factor, a rheumatoid arthritis-specific autoantigen, is not present in keratohyalin granules of cultured buccal mucosa cells.
Hoet RM; Voorsmit RA; Van Venrooij WJ
Clin Exp Immunol; 1991 Apr; 84(1):59-65. PubMed ID: 1849807
[TBL] [Abstract][Full Text] [Related]
8. The antiperinuclear factor. II. Variability of the perinuclear antigen.
Youinou P; Seigneurin JM; Le Goff P; Dumay A; Vicariot M; Lelong A
Clin Exp Rheumatol; 1990; 8(3):265-9. PubMed ID: 2165883
[TBL] [Abstract][Full Text] [Related]
9. Lytic Epstein-Barr virus infection in the synovial tissue of patients with rheumatoid arthritis.
Takeda T; Mizugaki Y; Matsubara L; Imai S; Koike T; Takada K
Arthritis Rheum; 2000 Jun; 43(6):1218-25. PubMed ID: 10857780
[TBL] [Abstract][Full Text] [Related]
10. Clinical heterogeneity of rheumatoid arthritis and the antiperinuclear factor.
Manera C; Franceschini F; Cretti L; Braga S; Cattanec R
J Rheumatol; 1994 Nov; 21(11):2021-5. PubMed ID: 7869304
[TBL] [Abstract][Full Text] [Related]
11. Clinical and immunological considerations in Epstein-Barr virus-associated diseases.
Andersson J
Scand J Infect Dis Suppl; 1996; 100():72-82. PubMed ID: 8860357
[TBL] [Abstract][Full Text] [Related]
12. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus and rheumatoid arthritis.
Balandraud N; Roudier J; Roudier C
Autoimmun Rev; 2004 Jul; 3(5):362-7. PubMed ID: 15288002
[TBL] [Abstract][Full Text] [Related]
14. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process.
Aho K; von Essen R; Kurki P; Palosuo T; Heliövaara M
J Rheumatol; 1993 Aug; 20(8):1278-81. PubMed ID: 7693940
[TBL] [Abstract][Full Text] [Related]
15. Synovial Epstein-Barr virus infection increases the risk of rheumatoid arthritis in individuals with the shared HLA-DR4 epitope.
Saal JG; Krimmel M; Steidle M; Gerneth F; Wagner S; Fritz P; Koch S; Zacher J; Sell S; Einsele H; Müller CA
Arthritis Rheum; 1999 Jul; 42(7):1485-96. PubMed ID: 10403278
[TBL] [Abstract][Full Text] [Related]
16. Infrequent detection of cytomegalovirus and Epstein-Barr virus DNA in synovial membrane of patients with rheumatoid arthritis.
Mousavi-Jazi M; Boström L; Lövmark C; Linde A; Brytting M; Sundqvist VA
J Rheumatol; 1998 Apr; 25(4):623-8. PubMed ID: 9558160
[TBL] [Abstract][Full Text] [Related]
17. ELISA for the detection of serum and saliva IgA against the BMRFI gene product of Epstein-Barr virus.
Nadala EC; Tan TM; Wong HM; Ting RC
J Med Virol; 1996 Sep; 50(1):93-6. PubMed ID: 8890046
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus and rheumatoid arthritis: are rheumatoid arthritis associated nuclear antigen and Epstein-Barr virus nuclear antigen different?
Cohen JH; Lenoir GM
Biomed Pharmacother; 1982; 36(5):246-9. PubMed ID: 6301567
[TBL] [Abstract][Full Text] [Related]
19. Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.
Klatt T; Ouyang Q; Flad T; Koetter I; Bühring HJ; Kalbacher H; Pawelec G; Müller CA
J Rheumatol; 2005 Feb; 32(2):239-51. PubMed ID: 15693083
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus (EBV). V. Incidence of EBV antibodies in patients with rheumatic diseases.
Pătraşcu IV; Ghenoiu O; Tache M
Virologie; 1989; 40(1):25-9. PubMed ID: 2549699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
